Difficulty: Medium
Average Score: 76%
Practice
Transgender men who are receiving testosterone therapy should have monitoring of:
Correct answer
D
Rationale
Choice D is correct because testosterone therapy in transgender men can raise lipids (CVD risk), increase hemoglobin/hematocrit (polycythemia), and affect liver function, requiring monitoring per guidelines. Choice A is incorrect alone as lipids are one aspect. Choice B is wrong by itself because hematocrit is just part. Choice C is incorrect solo since liver is only one factor.